Roy Alcalay

Alfred and Minnie Bressler Associate Professor of Neurology

Columbia University Columbia College

United States

Research Interests

Explore related searches

Professors in United States Professors in Medical Science Medical Science professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Roy Alcalay is the Alfred and Minnie Bressler Associate Professor of Neurology at Columbia University Columbia College in the United States. His research focuses on Parkinson's disease, particularly in the areas of genetic testing, biomarkers, and the impact of COVID-19 on patients with movement disorders. Recent publications include studies on glucocerebrosidase activity, neuropsychiatric symptoms in Parkinson's disease, and the clinical characteristics of LRRK2-related conditions.

Articles (10)

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (5)

Matthew Barrett

Associate Professor

University of Virginia Health System

UNITED STATES

View details

Clemens Scherzer

Professor of Neurology

Harvard Medical School

UNITED STATES

View details

James Beck

Chief Scientific Officer

UNITED STATES

View details

Yen Tai

Imperial College London

UNITED KINGDOM

View details

Nicolas Dzamko

University of Sydney

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Roy Alcalay

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Cytokines and Gaucher Biomarkers in Glucocerebrosidase Carriers with and Without Parkinson Disease

Genetic Testing for Parkinson Disease

The impact of COVID-19 and social distancing on people with Parkinson’s disease: a survey study

Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson disease.

Longitudinal Measurements of Glucocerebrosidase activity in Parkinson’s patients

Cerebrospinal fluid proteomics implicates the granin family in Parkinson's disease.

Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross‐Sectional Study

Movement disorders rounds: A case of missing pathology in a patient with LRRK2 Parkinson's disease

Genetic testing for Parkinson disease: current practice, knowledge, and attitudes among US and Canadian movement disorders specialists

Correction: Genetic testing for Parkinson disease: current practice, knowledge, and attitudes among US and Canadian movement disorders specialists

Collaborators (5)

Matthew Barrett

Clemens Scherzer

James Beck

Yen Tai

Nicolas Dzamko

Make your next move.